Pursue Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Pursue Wealth Partners's LLY Position: Q1 2026 in Review
Pursue Wealth Partners reduced its Eli Lilly (LLY) stake by 0.37% in Q1 2026, selling an estimated $8.11K and leaving 2,128 shares worth $1.96M. The position accounts for 1.17% of the portfolio, ranked #27.
Pursue Wealth Partners first reported a position in LLY in Q1 2022 and has held it in 5 quarters since. The position peaked at $2.3M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Pursue Wealth Partners held 2,128 shares of Eli Lilly worth $1.96M as of Q1 2026.
- Pursue Wealth Partners sold 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
- Eli Lilly made up 1.17% of Pursue Wealth Partners's portfolio in Q1 2026, its #27 holding.
- Pursue Wealth Partners first reported a position in Eli Lilly in Q1 2022 and has held it in 5 quarters since.
- Pursue Wealth Partners's Eli Lilly position peaked at $2.3M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Pursue Wealth Partners's 13F filing for Q1 2026, filed 8 Apr 2026.